Last Updated: November 8, 2026

Details for New Drug Application (NDA): 021902

NDA 021902 describes VEREGEN, which is a drug marketed by Ani Pharms and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the VEREGEN profile page.

The generic ingredient in VEREGEN is sinecatechins. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the sinecatechins profile page.

Summary for 021902

Tradename:	VEREGEN
Applicant:	Ani Pharms
Ingredient:	sinecatechins
Patents:	1

Suppliers and Packaging for NDA: 021902

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
VEREGEN	sinecatechins	OINTMENT;TOPICAL	021902	NDA	ANI Pharmaceuticals, Inc.	62559-385	62559-385-26	6 CARTON in 1 CARTON (62559-385-26) / 1 TUBE in 1 CARTON (62559-385-02) / 2 g in 1 TUBE
VEREGEN	sinecatechins	OINTMENT;TOPICAL	021902	NDA	ANI Pharmaceuticals, Inc.	62559-385	62559-385-30	1 TUBE in 1 CARTON (62559-385-30) / 30 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	OINTMENT;TOPICAL			Strength	15%
Approval Date:	Oct 31, 2006	TE:		RLD:	Yes
Patent:	⤷ Start Trial	Patent Expiration:	Oct 2, 2026	Product Flag?	Y	Substance Flag?		Delist Request?
Patented Use:	TREATMENT OF GENITAL WARTS

Expired US Patents for NDA 021902

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ani Pharms	VEREGEN	sinecatechins	OINTMENT;TOPICAL	021902-001	Oct 31, 2006	⤷ Start Trial	⤷ Start Trial
Ani Pharms	VEREGEN	sinecatechins	OINTMENT;TOPICAL	021902-001	Oct 31, 2006	⤷ Start Trial	⤷ Start Trial
Ani Pharms	VEREGEN	sinecatechins	OINTMENT;TOPICAL	021902-001	Oct 31, 2006	⤷ Start Trial	⤷ Start Trial
Ani Pharms	VEREGEN	sinecatechins	OINTMENT;TOPICAL	021902-001	Oct 31, 2006	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.